Discover 616 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma City offers many opportunities for both healthy volunteers and individuals with specific health concerns to participate in clinical research. Participants have the opportunity to explore innovative treatments and contribute to the advancement of medical science for conditions such as depression, pulmonary fibrosis, and various neurological disorders.
Filter
2
Filter results
Results: 616
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Oklahoma City OK, Flower Mound TX, Little Rock AR, Austin TX,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
Location: Oklahoma City OK, Wichita KS, Dallas TX, Kansas City KS,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Active & Responsive
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
for
Ovarian Cancer
Location: Oklahoma City OK, Austin TX, Houston TX, San Antonio TX,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 50 - 70+
Code: NCT00539162
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Active & Responsive
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for
Primary Immune Thrombocytopenia (ITP)
Location: Oklahoma City OK, Iowa City IA, Oceanside CA,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06544499
Phase3, Recruiting
Active & Responsive
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies